Enrico Martin

83 Treatment and survival in pediatric MPNST 15. van Noesel MM, Orbach D, Brennan B, et al. Outcome and prognostic factors in pediatric malignant peripheral nerve sheath tumors: An analysis of the European Pediatric Soft Tissue Sarcoma Group (EpSSG) NRSTS-2005 prospective study. Pediatr Blood Cancer . 2019;66(10):e27833. doi:10.1002 / pbc.27833 16. Ferrari A, Miceli R, Rey A, et al. Non- metastatic unresected paediatric non- rhabdomyosarcoma soft tissue sarcomas: results of a pooled analysis from United States and European groups. Eur J Cancer . 2011;47(5):724-731. doi:10.1016/j. ejca.2010.11.013 17. Kahn J, Gillespie A, Tsokos M, et al. Radiation therapy in management of sporadic and neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors. Front Oncol . 2014;4:324. doi:10.3389/fonc.2014.00324 18. Bradford D, Kim A. Current treatment options for malignant peripheral nerve sheath tumors. Curr Treat Options Oncol . 2015;16(3):328. doi:10.1007/s11864-015- 0328-6 19. Waxweiler T V, Rusthoven CG, Proper MS, et al. Non-Rhabdomyosarcoma Soft Tissue Sarcomas in Children : A Surveillance , Epidemiology , and End Results Analysis Validating COG Risk Stratifications. Radiat Oncol Biol . 2015;92(2):339-348. doi:10.1016/j.ijrobp.2015.02.007 20. Kolberg M, Holand M, Agesen TH, et al. Survival meta-analyses for >1800 malignant peripheral nerve sheath tumor patients with and without neurofibromatosis type 1. Neuro Oncol . 2013;15(2):135-147. doi:10.1093/neuonc/ nos287 21. Martin E, Coert JH, Flucke UE, et al. A nationwide cohort study on treatment and survival in patients with malignant peripheral nerve sheath tumours. Eur J Cancer . 2019;124:77-87. doi:10.1016/j. ejca.2019.10.014 22. Casparie M, Tiebosch ATMG, Burger G, et al. Pathology databanking and biobanking in The Netherlands, a central role for PALGA, the nationwide histopathology and cytopathology data network and archive. Cell Oncol . 2007;29(1):19-24. 23. Therneau TM, Crowson CS, Elizabeth AJ. Adjusted Survival Curves. cran.r-project. org/web/packages/sur vival/vignet tes/ adjcurve.pdf . 24. deCou JM, Rao BN, Parham DM, et al. Malignant peripheral nerve sheath tumors: the St. Jude Children’s Research Hospital experience. Ann Surg Oncol . 1995;2(6):524-529. 25. Demir HA, Varan A, Yalcn B, Akyuz C, Kutluk T, Buyukpamukcu M. Malignant peripheral nerve sheath tumors in childhood: 13 cases from a single center. J Pediatr Hematol Oncol . 2012;34(3):204-207. doi:10.1097/MPH.0b013e31822d4cef 26. Raney B, Schnaufer L, Ziegler M, Chatten J, Littman P, Jarrett P. Treatment of children with neurogenic sarcoma. Experience at the Children’s Hospital of Philadelphia, 1958-1984. Cancer . 1987;59(1):1-5. 27. Meis JM, Enzinger FM, Martz KL, Neal JA. Malignant peripheral nerve sheath tumors (malignant schwannomas) in children. Am J Surg Pathol . 1992;16(7):694-707. 28. Ducatman BS, Scheithauer BW, Piepgras DG, Reiman HM. Malignant peripheral nerve sheath tumors in childhood. J Neurooncol . 1984;2(3):241-248. 29. Amirian ES, Goodman JC, New P, Scheurer ME. Pediatric and adult malignant peripheral nerve sheath tumors : an analysis of data from the surveillance , epidemiology , and end results program. 2014:609-616. doi:10.1007/s11060-013- 1345-6 30. Anghileri M, Miceli R, Fiore M, et al. Malignant peripheral nerve sheath tumors: prognostic factors and survival in a series of patients treated at a single institution. Cancer . 2006;107(5):1065-1074. doi:10.1002/cncr.22098 4